Antiretroviral drugs have had a profound effect on AIDS, however, long-term toxicity of the drugs can be a problem. Fortunately, efforts to discover different classes of AIDS drugs have been successful. The different classes are possible because of knowledge about the life cycle of HIV. Here is a simplified explanation of how this works.
A recent study, published in the Annals of Internal Medicine, claims the cost-effectiveness of providing pre-exposure prophylaxis (PrEP) to individuals who engage in injected drug use. Outside of a controlled clinical setting, however, this would not be a wise public health choice.
Truvada has repeatedly been shown to prevent sexual transmission of HIV. Yet women require more of the drug than men for protection from infection, according to a new study published in the Journal of Infectious Diseases.
Until recently, it looked like the African AIDS epidemic might finally be controlled, with the widespread use of anti-retroviral (ARV) drugs. But poor compliance has caused HIV to mutate in a way such that tenofovir, one of the most important ARV drugs, often no longer works, threatening not only Africa, but world as well.
Truvada, a prescription drug used to prevent HIV infection, was recommended earlier this year by the CDC in combination with condoms for high-risk individuals. However, despite
If there is a better example of the law of unintended consequences we have never seen it. The incredibly successful battle against HIV/AIDS has saved many lives, and will no doubt continue to save many more. Once HAART (highly active antiretroviral therapy) drugs, aka cocktails, became available in 1995, there was a steep drop in the number of AIDS deaths in the US.